Mechanisms of blunted muscle vasodilation during peripheral chemoreceptor stimulation in heart failure patients


Autoria(s): Alves, M. J. N. N.; Santos, Marcelo Rodrigues dos; Nobre, Thais Simoes; Martinez, Dg; Barretto, Antonio Carlos Pereira; Brum, Patricia Chakur; Rondon, Maria Urbana P. B.; Middlekauff, Holly R.; Negrão, Carlos Eduardo
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

06/11/2013

06/11/2013

2012

Resumo

We described recently that systemic hypoxia provokes vasoconstriction in heart failure (HF) patients. We hypothesized that either the exaggerated muscle sympathetic nerve activity and/or endothelial dysfunction mediate the blunted vasodilatation during hypoxia in HF patients. Twenty-seven HF patients and 23 age-matched controls were studied. Muscle sympathetic nerve activity was assessed by microneurography and forearm blood flow (FBF) by venous occlusion plethysmography. Peripheral chemoreflex control was evaluated through the inhaling of a hypoxic gas mixture (10% O-2 and 90% N-2). Basal muscle sympathetic nerve activity was greater and basal FBF was lower in HF patients versus controls. During hypoxia, muscle sympathetic nerve activity responses were greater in HF patients, and forearm vasodilatation in HF was blunted versus controls. Phentolamine increased FBF responses in both groups, but the increase was lower in HF patients. Phentolamine and N-G-monomethyl-L-arginine infusion did not change FBF responses in HF but markedly blunted the vasodilatation in controls. FBF responses to hypoxia in the presence of vitamin C were unchanged and remained lower in HF patients versus controls. In conclusion, muscle vasoconstriction in response to hypoxia in HF patients is attributed to exaggerated reflex sympathetic nerve activation and blunted endothelial function (NO activity). We were unable to identify a role for oxidative stress in these studies. (Hypertension. 2012; 60: 669-676.) . Online Data Supplement

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/50048-1]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Pesquisa [CNPq 475442/2007-5, CNPq 301867/2010-0, 302201/2011-4, 308068/2011-4]

Conselho Nacional de Pesquisa

Identificador

HYPERTENSION, PHILADELPHIA, v. 60, n. 3, supl. 1, Part 1, pp. 669-+, SEP, 2012

0194-911X

http://www.producao.usp.br/handle/BDPI/42122

10.1161/HYPERTENSIONAHA.112.195776

http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.195776

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

PHILADELPHIA

Relação

HYPERTENSION

Direitos

closedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #HEART FAILURE #CHEMORECEPTORS #VASODILATION #SYMPATHETIC NERVOUS SYSTEM #ENDOTHELIUM #SYMPATHETIC-NERVE ACTIVITY #NITRIC-OXIDE #BAROREFLEX CONTROL #CHEMOREFLEX ACTIVATION #RESISTANCE ARTERIES #SKELETAL-MUSCLE #HUMANS #HYPOXIA #RESPONSES #NOREPINEPHRINE #PERIPHERAL VASCULAR DISEASE
Tipo

article

original article

publishedVersion